𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Practice effects in a longitudinal, multi-center Alzheimer’s disease prevention clinical trial

✍ Scribed by Erin L Abner, Brandon C Dennis, Melissa J Mathews, Marta S Mendiondo, Allison Caban-Holt, Richard J Kryscio, Frederick A Schmitt, John J Crowley

Book ID
119909732
Publisher
BioMed Central
Year
2012
Tongue
English
Weight
224 KB
Volume
13
Category
Article
ISSN
1468-6708

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Analysis of longitudinal data in an Alzh
Analysis of longitudinal data in an Alzheimer's disease clinical trial
✍ Ronald G. Thomas; Julie D. Berg; Mary Sano; Leon Thal 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

Evidence of delayed progression is the primary mechanism for demonstrating therapeutic e cacy in clinical trials in Alzheimer's disease. In the major trials of therapeutic treatment of AD, to date, measures based on clinical judgement and cognitive performance, instead of mortality, have been used a